Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim
Crossref DOI link: https://doi.org/10.1007/s00520-015-2834-2
Published Online: 2015-07-11
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, H.
Gong, Q.
Vogl, F. D.
Reiner, M.
Page, J. H.
Text and Data Mining valid from 2015-07-11
